These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21470277)

  • 1. Effect of letrozole for ovulation induction combined with intrauterine insemination on women with polycystic ovary syndrome.
    Nguyen TT; Doan HT; Quan LH; Lam NM
    Gynecol Endocrinol; 2020 Oct; 36(10):860-863. PubMed ID: 32241195
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational screening of FDA-approved drugs to identify potential aromatase receptor inhibitors for polycystic ovary syndrome.
    Koohnavard F; Ahmadi K; Eftekhar E; Edalatmanesh MA
    J Biomol Struct Dyn; 2023; 41(24):15507-15519. PubMed ID: 36940361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Anti-Müllerian Hormone in Predicting Ovulation Induced by Aromatase Inhibitors in Women With Polycystic Ovary Syndrome.
    Le NSV; Le MT; Tran NQT; Nguyen QHV; Cao TN
    J Obstet Gynaecol Can; 2023 Nov; 45(11):102183. PubMed ID: 37453589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin D in addition to letrozole on the ovulation rate of women with polycystic ovary syndrome: protocol of a multicentre randomised double-blind controlled trial.
    Ko JKY; Yung SSF; Lai SF; Wan RSF; Wong CKY; Wong K; Cheung CL; Ng EHY; Li RHW
    BMJ Open; 2024 Apr; 14(4):e070801. PubMed ID: 38684265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.
    Kawahara T; Okamoto N; Takae S; Kashiwagi M; Nakajima M; Uekawa A; Ito J; Kashiwazaki N; Sugishita Y; Suzuki N
    Hum Reprod; 2018 Feb; 33(2):303-310. PubMed ID: 29300901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Casper RF; Mitwally MF
    Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibitors for PCOS: a systematic review and meta-analysis.
    Misso ML; Wong JL; Teede HJ; Hart R; Rombauts L; Melder AM; Norman RJ; Costello MF
    Hum Reprod Update; 2012; 18(3):301-12. PubMed ID: 22431566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
    Franik S; Le QK; Kremer JA; Kiesel L; Farquhar C
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD010287. PubMed ID: 36165742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.
    Namavar Jahromi B; Parsanezhad ME; Shomali Z; Bakhshai P; Alborzi M; Moin Vaziri N; Anvar Z
    Iran J Med Sci; 2018 May; 43(3):248-260. PubMed ID: 29892142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
    Franik S; Eltrop SM; Kremer JA; Kiesel L; Farquhar C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010287. PubMed ID: 29797697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence?
    Abu Hashim H
    Int J Fertil Steril; 2016; 10(3):270-277. PubMed ID: 27695608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin Decreases Aromatase Gene Expression in The Hypothalamus of Androgenized Female Rats.
    Salimi M; Alishah Z; Khazali H; Mahmoudi F
    Int J Fertil Steril; 2016; 10(2):190-5. PubMed ID: 27441052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Ovarian Hyperstimulation Syndrome: A Review.
    Smith V; Osianlis T; Vollenhoven B
    Obstet Gynecol Int; 2015; 2015():514159. PubMed ID: 26074966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination.
    Yun BH; Chon SJ; Park JH; Seo SK; Cho S; Choi YS; Kim SH; Lee BS
    Yonsei Med J; 2015 Mar; 56(2):490-6. PubMed ID: 25684000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com.
    Brezina PR; Mensah V; Balen A; Leong M; Weissman A; Zhao Y; Shoham Z
    J Assist Reprod Genet; 2013 Sep; 30(9):1169-74. PubMed ID: 23897006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.
    Pavone ME; Bulun SE
    J Clin Endocrinol Metab; 2013 May; 98(5):1838-44. PubMed ID: 23585659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors for ovulation induction and ovarian stimulation.
    Lee VC; Ledger W
    Clin Endocrinol (Oxf); 2011 May; 74(5):537-46. PubMed ID: 21470277
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.